
Home » Prescription Drugs 13 » PARAXIN Chloromycetin
Chloramphenicol is primarily bacteriostatic. It binds to the 50S subunit of the ribosome thereby inhibiting bacterial protein synthesis.Chloramphenicol has a wide spectrum of activity against gram-positive and gram-negative cocci and bacilli (including anaerobes) Rickettsia Mycoplasma and Chlamydia and Chlamydophila. Because of bone marrow toxicity the availability of alternative antibiotics and the emergence of resistance chloramphenicol is no longer a drug of choice for any infection except serious infections due to a few multidrug-resistant pathogens that retain susceptibility to this antibiotic. However outcomes of chloramphenicol treatment of meningitis caused by relatively penicillin-resistant pneumococci have been discouraging.
Buy PARAXIN Chloromycetin and other Prescription Drugs 13 products online
at Medstore.
882 Buy Online at Medstore - Click Here!

About PARAXIN Chloromycetin:
Product Type: Prescription Drugs 13
PARAXIN ( Chloromycetin Generic Chloramphenicol )
PARAXIN (Chloromycetin Generic Chloramphenicol)
Chloromycetin Generic Chloramphenicol
250mg Caps 10
Chloromycetin Generic Chloramphenicol PARAXIN

View more
Prescription Drugs 13
Previous Product Next Product
Pharmacy:
Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide:
Which drugs are scheduled to go generic?
Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.


|